These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1428461)
81. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids. Karaki M; Akiyama K; Mori N Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728 [TBL] [Abstract][Full Text] [Related]
82. Improvement in Extensive Moderate Plaque Psoriasis With a Novel Emollient Spray Formulation of Betamethasone Dipropionate 0.05. Stein Gold L; Jackson JM; Knuckles ML; Weiss JS J Drugs Dermatol; 2016 Mar; 15(3):334-42. PubMed ID: 26954319 [TBL] [Abstract][Full Text] [Related]
83. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids. Poulsen BJ; Burdick K; Bessler S Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938 [No Abstract] [Full Text] [Related]
84. Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence. Shah VP; Flynn GL; Yacobi A; Maibach HI; Bon C; Fleischer NM; Franz TJ; Kaplan SA; Kawamoto J; Lesko LJ; Marty JP; Pershing LK; Schaefer H; Sequeira JA; Shrivastava SP; Wilkin J; Williams RL Pharm Res; 1998 Feb; 15(2):167-71. PubMed ID: 9523299 [No Abstract] [Full Text] [Related]
85. Issues in measuring percutaneous absorption of topical corticosteroids. Maibach HI; Wester RC Int J Dermatol; 1992 Oct; 31 Suppl 1():21-5. PubMed ID: 1428463 [TBL] [Abstract][Full Text] [Related]
86. Topical delivery of lipophilic drugs from o/w Pickering emulsions. Frelichowska J; Bolzinger MA; Pelletier J; Valour JP; Chevalier Y Int J Pharm; 2009 Apr; 371(1-2):56-63. PubMed ID: 19135516 [TBL] [Abstract][Full Text] [Related]
87. Optimization of bioavailability of topical steroids: penetration enhancers under occlusion. Barry BW; Southwell D; Woodford R J Invest Dermatol; 1984 Jan; 82(1):49-52. PubMed ID: 6690630 [TBL] [Abstract][Full Text] [Related]
88. FDA critical path initiatives: opportunities for generic drug development. Lionberger RA AAPS J; 2008; 10(1):103-9. PubMed ID: 18446510 [TBL] [Abstract][Full Text] [Related]
89. Topical 0.050% betamethasone dipropionate. Pharmacokinetic and pharmacodynamic dose-response studies in humans. Pershing LK; Lambert L; Wright ED; Shah VP; Williams RL Arch Dermatol; 1994 Jun; 130(6):740-7. PubMed ID: 8002644 [TBL] [Abstract][Full Text] [Related]
90. Circadian activity of topical 0.05% betamethasone dipropionate in human skin in vivo. Pershing LK; Corlett JL; Lambert LD; Poncelet CE J Invest Dermatol; 1994 May; 102(5):734-9. PubMed ID: 8176255 [TBL] [Abstract][Full Text] [Related]
91. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability. Wiedersberg S; Naik A; Leopold CS; Guy RH Br J Dermatol; 2009 Mar; 160(3):676-86. PubMed ID: 18782322 [TBL] [Abstract][Full Text] [Related]
92. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay. Pershing LK; Silver BS; Krueger GG; Shah VP; Skelley JP Pharm Res; 1992 Jan; 9(1):45-51. PubMed ID: 1589409 [TBL] [Abstract][Full Text] [Related]
93. New approaches to assess topical corticosteroid bioequivalence: pharmacokinetic evaluation. Pershing LK Int J Dermatol; 1992 Oct; 31 Suppl 1():14-20. PubMed ID: 1428461 [TBL] [Abstract][Full Text] [Related]
94. The vasoconstrictor assay in bioequivalence testing: practical concerns and recent developments. Stoughton RB Int J Dermatol; 1992 Oct; 31 Suppl 1():26-8. PubMed ID: 1428464 [TBL] [Abstract][Full Text] [Related]